FDA Inspection 1283510 — Lundbeck Seattle BioPharmaceuticals, Inc.
The FDA completed an inspection of Lundbeck Seattle BioPharmaceuticals, Inc. on Sep 12, 2025 in Bothell, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 12, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bothell, WA (United States)
Additional Details
Sponsor, Contract Research Organization